Armata Pharmaceuticals Statistics
Total Valuation
ARMP has a market cap or net worth of $81.41 million. The enterprise value is $199.92 million.
Important Dates
The last earnings date was Wednesday, May 14, 2025, after market close.
| Earnings Date | May 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ARMP has 36.18 million shares outstanding. The number of shares has increased by 0.22% in one year.
| Current Share Class | 36.18M |
| Shares Outstanding | 36.18M |
| Shares Change (YoY) | +0.22% |
| Shares Change (QoQ) | +0.67% |
| Owned by Insiders (%) | 0.27% |
| Owned by Institutions (%) | 2.05% |
| Float | 11.01M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 17.32 |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 42.55 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.12
| Current Ratio | 0.12 |
| Quick Ratio | 0.11 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -3.23 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -24.32% |
| Return on Invested Capital (ROIC) | -26.89% |
| Return on Capital Employed (ROCE) | 173.46% |
| Revenue Per Employee | $78,317 |
| Profits Per Employee | -$7,100 |
| Employee Count | 60 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -13.13% in the last 52 weeks. The beta is 0.92, so ARMP's price volatility has been similar to the market average.
| Beta (5Y) | 0.92 |
| 52-Week Price Change | -13.13% |
| 50-Day Moving Average | 1.50 |
| 200-Day Moving Average | 2.04 |
| Relative Strength Index (RSI) | 71.30 |
| Average Volume (20 Days) | 598,919 |
Short Selling Information
The latest short interest is 7,525, so 0.02% of the outstanding shares have been sold short.
| Short Interest | 7,525 |
| Short Previous Month | 3,633 |
| Short % of Shares Out | 0.02% |
| Short % of Float | 0.07% |
| Short Ratio (days to cover) | 0.33 |
Income Statement
In the last 12 months, ARMP had revenue of $4.70 million and -$426,000 in losses. Loss per share was -$1.09.
| Revenue | 4.70M |
| Gross Profit | -29.73M |
| Operating Income | -40.40M |
| Pretax Income | -79.58M |
| Net Income | -426,000 |
| EBITDA | -39.01M |
| EBIT | -40.40M |
| Loss Per Share | -$1.09 |
Full Income StatementBalance Sheet
The company has $11.69 million in cash and $130.20 million in debt, giving a net cash position of -$118.51 million or -$3.28 per share.
| Cash & Cash Equivalents | 11.69M |
| Total Debt | 130.20M |
| Net Cash | -118.51M |
| Net Cash Per Share | -$3.28 |
| Equity (Book Value) | -53.78M |
| Book Value Per Share | -1.49 |
| Working Capital | -97.37M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$34.55 million and capital expenditures -$1.73 million, giving a free cash flow of -$36.28 million.
| Operating Cash Flow | -34.55M |
| Capital Expenditures | -1.73M |
| Free Cash Flow | -36.28M |
| FCF Per Share | -$1.00 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -859.74% |
| Pretax Margin | -9.07% |
| Profit Margin | -9.07% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |